Drug supply for children with psoriasis in Germany
Standard
Drug supply for children with psoriasis in Germany. / Augustin, Matthias; Reich, Kristian; Glaeske, Gerd; Kämpfe, Susann; Radtke, Marc Alexander; Gerdau-Heitmann, Cornelia; Schicktanz, Christel; Schäfer, Ines.
In: J DTSCH DERMATOL GES, Vol. 11, No. 8, 01.08.2013, p. 751-5.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Drug supply for children with psoriasis in Germany
AU - Augustin, Matthias
AU - Reich, Kristian
AU - Glaeske, Gerd
AU - Kämpfe, Susann
AU - Radtke, Marc Alexander
AU - Gerdau-Heitmann, Cornelia
AU - Schicktanz, Christel
AU - Schäfer, Ines
N1 - © The Authors • Journal compilation © Blackwell Verlag GmbH, Berlin.
PY - 2013/8/1
Y1 - 2013/8/1
N2 - BACKGROUND: In Germany there is a lack of robust nationwide data on psoriasis therapy in children.PATIENTS AND METHODS: Secondary data from the statutory health insurance Gmnder Ersatzkasse (GEK) of the year 2009 were analyzed. Continuously insured children with psoriasis vulgaris were identified by ICD-10 codes (L 40. X). Their treatment was determined on the basis of prescriptions according to ATC code.RESULTS: 1,313 of 293,181 children and adolescents had psoriasis (0.45%). Of these, n = 651 (49.6%) received at least one medication during the observation period. Topical and systemic corticosteroids were most frequently prescribed (70.8% and 4.0% respectively). The relative frequency of prescription of systemic corticosteroids was higher in children treated by pediatricians and family physicians (by a factor of 3 and 5, respectively) than in those treated by dermatologists. Vitamin D analogs were the second most frequently prescribed drugs, used far more often by dermatologists (14.7%) than by general practitioners (1.7%) and pediatricians (0.9%).CONCLUSIONS: Drug supply for children with psoriasis in Germany appears to be inadequate. The consensus guidelines are not sufficiently considered and the use of systemic corticosteroids is still too high, even after adjustment for steroid-dependent indications. The data underline the necessity of guideline-oriented therapy and implementation of current therapeutic evidence in juvenile psoriasis.
AB - BACKGROUND: In Germany there is a lack of robust nationwide data on psoriasis therapy in children.PATIENTS AND METHODS: Secondary data from the statutory health insurance Gmnder Ersatzkasse (GEK) of the year 2009 were analyzed. Continuously insured children with psoriasis vulgaris were identified by ICD-10 codes (L 40. X). Their treatment was determined on the basis of prescriptions according to ATC code.RESULTS: 1,313 of 293,181 children and adolescents had psoriasis (0.45%). Of these, n = 651 (49.6%) received at least one medication during the observation period. Topical and systemic corticosteroids were most frequently prescribed (70.8% and 4.0% respectively). The relative frequency of prescription of systemic corticosteroids was higher in children treated by pediatricians and family physicians (by a factor of 3 and 5, respectively) than in those treated by dermatologists. Vitamin D analogs were the second most frequently prescribed drugs, used far more often by dermatologists (14.7%) than by general practitioners (1.7%) and pediatricians (0.9%).CONCLUSIONS: Drug supply for children with psoriasis in Germany appears to be inadequate. The consensus guidelines are not sufficiently considered and the use of systemic corticosteroids is still too high, even after adjustment for steroid-dependent indications. The data underline the necessity of guideline-oriented therapy and implementation of current therapeutic evidence in juvenile psoriasis.
KW - Adolescent
KW - Adrenal Cortex Hormones
KW - Child
KW - Child, Preschool
KW - Dermatologic Agents
KW - Drug Utilization Review
KW - Female
KW - Germany
KW - Humans
KW - Infant
KW - Infant, Newborn
KW - Male
KW - Physician's Practice Patterns
KW - Prescriptions
KW - Prevalence
KW - Psoriasis
KW - Risk Factors
KW - Vitamin D
U2 - 10.1111/ddg.12102
DO - 10.1111/ddg.12102
M3 - SCORING: Journal article
C2 - 23718227
VL - 11
SP - 751
EP - 755
JO - J DTSCH DERMATOL GES
JF - J DTSCH DERMATOL GES
SN - 1610-0379
IS - 8
ER -